NCT00280046View on ClinicalTrials.gov

Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

307

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

biphasic insulin aspart

Trial Locations (11)

163045

Novo Nordisk Investigational Site, Arkhangelsk

194291

Novo Nordisk Investigational Site, Saint Petersburg

308007

Novo Nordisk Investigational Site, Belgorod

394053

Novo Nordisk Investigational Site, Voronezh

420064

Novo Nordisk Investigational Site, Kazan'

603126

Novo Nordisk Investigational Site, Nizhny Novgorod

620102

Novo Nordisk Investigational Site, Yekaterinburg

630090

Novo Nordisk Investigational Site, Novosibirsk

644070

Novo Nordisk Investigational Site, Omsk

680067

Novo Nordisk Investigational Site, Khabarovsk

690105

Novo Nordisk Investigational Site, Vladivostok

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY